UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010936
Receipt number R000010080
Scientific Title The effect of vasoconstriction agent for FloTrac system (cardiac output measurement device by arterial blood pressure wave form)
Date of disclosure of the study information 2013/07/01
Last modified on 2018/12/26 17:13:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of vasoconstriction agent for FloTrac system (cardiac output measurement device by arterial blood pressure wave form)

Acronym

The effect of vasoconstriction agent for FloTrac system

Scientific Title

The effect of vasoconstriction agent for FloTrac system (cardiac output measurement device by arterial blood pressure wave form)

Scientific Title:Acronym

The effect of vasoconstriction agent for FloTrac system

Region

Japan


Condition

Condition

Elective surgery patient over 20 yrs

Classification by specialty

Anesthesiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study aims to estimate the difference of measurements between objective device (FloTrac system) and control device (Ordinary cardiac output monitoring devices).

Basic objectives2

Others

Basic objectives -Others

Estimation of the accuracy of medical used device.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The difference of cardiac output measurements between FloTrac system and Ordinary cardiac output monitoring devices in anesthesia.

Key secondary outcomes

The existence of cardiac output measurements change in FloTrac system and Ordinary cardiac output monitoring devices in anesthesia.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Planned arterial catheterization.
Planned usage of vasoconstriction agent if necessary.
Pulmonary artery catheter and/or transesophageal ultrasonic cardiography planned.
Written informed consent

Key exclusion criteria

Diagnosis of moderate or severe arterial regargitation.(Except the patients who are expected to be corrected aortic regurgitation during surgery.)
Treated by intra aortic baloon pumping.
Pregnant woman.
Body mass index more than 40.
Body weight less than 40kg.
Participation to other studies which influence the measurements of this study.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masashi Kawamoto

Organization

Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University

Division name

Department of Anesthesiology and Critical Care

Zip code


Address

1-2-3,Kasumi,Minami-ku,Hiroshima

TEL

081-082-256-3234

Email

r-nacamura@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ryuji Nakamura

Organization

Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University

Division name

Department of Anesthesiology and Critical Care

Zip code


Address

1-2-3,Kasumi,Minami-ku,Hiroshima

TEL

081-082-256-3234

Homepage URL


Email

r-nacamura@hiroshima-u.ac.jp


Sponsor or person

Institute

Department of Anesthesiology and Critical Care, Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

広島大学病院


Other administrative information

Date of disclosure of the study information

2013 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 10 Month 01 Day

Last follow-up date

2014 Year 03 Month 31 Day

Date of closure to data entry

2014 Year 03 Month 31 Day

Date trial data considered complete

2014 Year 03 Month 31 Day

Date analysis concluded

2014 Year 03 Month 31 Day


Other

Other related information

None


Management information

Registered date

2013 Year 06 Month 12 Day

Last modified on

2018 Year 12 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010080


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name